Published in Diabetes Care on March 01, 1991
Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study | NCT00637520
The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med (2003) 10.84
The metabolic syndrome. Endocr Rev (2008) 5.33
Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels. J Clin Invest (2008) 3.51
Is there an association between shift work and having a metabolic syndrome? Results from a population based study of 27,485 people. Occup Environ Med (2001) 3.31
Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50-60 years. BMJ (1996) 3.23
Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia (2010) 3.17
alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One (2010) 2.94
Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest (1996) 2.82
Association analysis of the FTO gene with obesity in children of Caucasian and African ancestry reveals a common tagging SNP. PLoS One (2008) 2.67
The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ Health Perspect (2006) 2.59
Nutritional programming of the metabolic syndrome. Nat Rev Endocrinol (2009) 2.51
Phosphoenolpyruvate carboxykinase is necessary for the integration of hepatic energy metabolism. Mol Cell Biol (2000) 2.42
Relation between obesity from childhood to adulthood and the metabolic syndrome: population based study. BMJ (1998) 2.36
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J (2013) 2.02
Pathogenesis of insulin resistance in skeletal muscle. J Biomed Biotechnol (2010) 1.92
Elevated expression of transforming growth factor-beta in adipose tissue from obese mice. Mol Med (1997) 1.92
Effects of lifestyle modification on metabolic syndrome: a systematic review and meta-analysis. BMC Med (2012) 1.82
Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms. J Endocrinol (2014) 1.76
Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide. J Clin Invest (1996) 1.65
The relationship of retinol binding protein 4 to changes in insulin resistance and cardiometabolic risk in overweight black adolescents. J Pediatr (2008) 1.54
Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational study. BMJ (1996) 1.54
The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. II. An autosomal genome scan for diabetes-related quantitative-trait loci. Am J Hum Genet (2000) 1.53
Total and cause-specific mortality in the cardiovascular health study. J Gerontol A Biol Sci Med Sci (2009) 1.53
Androgen deprivation therapy for prostate cancer: new concepts and concerns. Curr Opin Endocrinol Diabetes Obes (2007) 1.49
The body politic: the relationship between stigma and obesity-associated disease. BMC Public Health (2008) 1.48
Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest (1996) 1.45
Left ventricular mass and arterial compliance: relation to coronary heart disease and its risk factors in South Indian adults. Int J Cardiol (2002) 1.44
Tissue factor gene expression in the adipose tissues of obese mice. Proc Natl Acad Sci U S A (1998) 1.44
Can "healthy" normal alanine aminotransferase levels identify the metabolically obese phenotype? Findings from the Korea national health and nutrition examination survey 2008-2010. Dig Dis Sci (2014) 1.43
Genetic and environmental architecture of the features of the insulin-resistance syndrome. Am J Hum Genet (1997) 1.42
Bromocriptine: a sympatholytic, d2-dopamine agonist for the treatment of type 2 diabetes. Diabetes Care (2011) 1.38
Evolution of insulin resistance in coronary artery disease patients on four different pharmacological therapies. Postgrad Med J (1999) 1.38
A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea. Sleep (2012) 1.37
Childhood obesity and risk of the adult metabolic syndrome: a systematic review. Int J Obes (Lond) (2011) 1.36
Toward a unifying hypothesis of metabolic syndrome. Pediatrics (2012) 1.36
Effects of GCK, GCKR, G6PC2 and MTNR1B variants on glucose metabolism and insulin secretion. PLoS One (2010) 1.33
Type 2 diabetes can be prevented with early pharmacological intervention. Diabetes Care (2011) 1.31
Omega-3 polyunsaturated fatty acid and insulin sensitivity: a meta-analysis of randomized controlled trials. Clin Nutr (2011) 1.30
Association of SIRT1 gene variation with visceral obesity. Hum Genet (2008) 1.29
The relationship between physical fitness and clustered risk, and tracking of clustered risk from adolescence to young adulthood: eight years follow-up in the Danish Youth and Sport Study. Int J Behav Nutr Phys Act (2004) 1.26
Prevalence and clinical characteristics of the metabolic syndrome in middle-aged Korean adults. Korean J Intern Med (2005) 1.25
Chronic administration of palmitoleic acid reduces insulin resistance and hepatic lipid accumulation in KK-Ay Mice with genetic type 2 diabetes. Lipids Health Dis (2011) 1.25
Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies. Vasc Health Risk Manag (2010) 1.24
The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome. Nutr Metab (Lond) (2005) 1.23
Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice. Am J Physiol Endocrinol Metab (2008) 1.23
The genetics of human obesity. Ann N Y Acad Sci (2013) 1.22
An integrated view of insulin resistance and endothelial dysfunction. Endocrinol Metab Clin North Am (2008) 1.22
Multiple lipolysis defects in the insulin resistance (metabolic) syndrome. J Clin Invest (1994) 1.22
A population-based risk algorithm for the development of diabetes: development and validation of the Diabetes Population Risk Tool (DPoRT). J Epidemiol Community Health (2010) 1.22
Pck1 gene silencing in the liver improves glycemia control, insulin sensitivity, and dyslipidemia in db/db mice. Diabetes (2008) 1.21
Role of insulin resistance in endothelial dysfunction. Rev Endocr Metab Disord (2013) 1.19
Practical way to assess metabolic syndrome using a continuous score obtained from principal components analysis. Diabetologia (2006) 1.19
Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis. Diabetes (2010) 1.19
Prevalence of metabolic syndrome in an adult urban population of the west of Iran. Exp Diabetes Res (2009) 1.18
Moderate alcohol consumption increases insulin sensitivity and ADIPOQ expression in postmenopausal women: a randomised, crossover trial. Diabetologia (2008) 1.18
Effect of acute physiological hyperinsulinemia on gene expression in human skeletal muscle in vivo. Am J Physiol Endocrinol Metab (2008) 1.17
Acanthosis Nigricans among Native Americans: an indicator of high diabetes risk. Am J Public Health (1994) 1.17
Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes Control (2012) 1.17
Metabolic function of the CTRP family of hormones. Rev Endocr Metab Disord (2014) 1.17
Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol (2013) 1.17
Protective effect of phosphatidylinositol 4,5-bisphosphate against cortical filamentous actin loss and insulin resistance induced by sustained exposure of 3T3-L1 adipocytes to insulin. J Biol Chem (2004) 1.15
Pressed for time: the circadian clock and hypertension. J Appl Physiol (1985) (2009) 1.15
Metabolic syndrome in adolescents with spinal cord dysfunction. J Spinal Cord Med (2007) 1.15
Improved Insulin Resistance and Lipid Metabolism by Cinnamon Extract through Activation of Peroxisome Proliferator-Activated Receptors. PPAR Res (2008) 1.15
Defining the genetic contribution of type 2 diabetes mellitus. J Med Genet (2001) 1.14
Human conditions of insulin-like growth factor-I (IGF-I) deficiency. J Transl Med (2012) 1.12
Markers of Oxidative Stress during Diabetes Mellitus. J Biomark (2013) 1.12
Glycated haemoglobin as a predictor for metabolic syndrome in non-diabetic Korean adults. Diabet Med (2007) 1.11
Muscle-specific vascular endothelial growth factor deletion induces muscle capillary rarefaction creating muscle insulin resistance. Diabetes (2012) 1.11
Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice. Mol Med (1996) 1.10
Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. Cardiovasc Diabetol (2014) 1.09
Obesity and cardiovascular risk in children and adolescents. Indian J Endocrinol Metab (2012) 1.08
Helicobacter pylori infection and its relationship to metabolic syndrome: is it a myth or fact? Saudi J Gastroenterol (2011) 1.08
Quercetin protects against diabetes-induced exaggerated vasoconstriction in rats: effect on low grade inflammation. PLoS One (2013) 1.07
Urological aspects of the metabolic syndrome. Nat Rev Urol (2011) 1.06
Diabetes is a proinflammatory state: a translational perspective. Expert Rev Endocrinol Metab (2010) 1.06
Prognostic significance of hemoglobin A1c level in patients hospitalized with coronary artery disease. A systematic review and meta-analysis. Cardiovasc Diabetol (2011) 1.05
Bromocriptine in type 2 diabetes mellitus. Indian J Endocrinol Metab (2011) 1.05
Prevalence of Metabolic Syndrome and its components in a Brazilian sample of pemphigus patients. An Bras Dermatol (2014) 1.05
Weight change and changes in the metabolic syndrome as the French population moves towards overweight: the D.E.S.I.R. cohort. Int J Epidemiol (2005) 1.03
Is metabolic syndrome a discrete entity in the general population? Evidence from the Caerphilly and Speedwell population studies. Heart (1998) 1.03
Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. Biochemical and molecular mechanisms. J Clin Invest (1996) 1.02
Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. Biomed Res Int (2014) 1.01
Beneficial effect of low ethanol intake on the cardiovascular system: possible biochemical mechanisms. Vasc Health Risk Manag (2006) 1.01
Insulin and atherosclerosis: villain, accomplice, or innocent bystander? Br Heart J (1993) 1.01
PPAR-gamma in the Cardiovascular System. PPAR Res (2008) 1.01
PPARγ Pro12Ala and ACE ID polymorphisms are associated with BMI and fat distribution, but not metabolic syndrome. Cardiovasc Diabetol (2011) 1.00
Central endocannabinoid signaling regulates hepatic glucose production and systemic lipolysis. Diabetes (2011) 1.00
Prevalence of metabolic syndrome and obesity-associated hypertension in the racial ethnic minorities of the United States. Curr Hypertens Rep (2014) 1.00
Red wine polyphenols prevent metabolic and cardiovascular alterations associated with obesity in Zucker fatty rats (Fa/Fa). PLoS One (2009) 0.99
Hyperinsulinemia and acanthosis nigricans in African Americans. J Natl Med Assoc (1997) 0.99
Enhanced adiponectin actions by overexpression of adiponectin receptor 1 in macrophages. Atherosclerosis (2013) 0.98
Results of pancreas transplantation with portal venous and enteric drainage. Ann Surg (1995) 0.98
Heritability and genetic correlations of insulin resistance and component phenotypes in Asian Indian families using a multivariate analysis. Diabetologia (2009) 0.97
Glucose tolerance, lipids, and GLP-1 secretion in JCR:LA-cp rats fed a high protein fiber diet. Obesity (Silver Spring) (2008) 0.97
A discrete Single Delay Model for the Intra-Venous Glucose Tolerance Test. Theor Biol Med Model (2007) 0.97
Genetics of childhood obesity. J Obes (2011) 0.97
New insights into insulin action and resistance in the vasculature. Ann N Y Acad Sci (2014) 0.97
Benign prostatic hyperplasia: from bench to clinic. Korean J Urol (2012) 0.96
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia (2012) 10.74
Pathogenesis of NIDDM. A balanced overview. Diabetes Care (1992) 6.56
Effect of fatty acids on glucose production and utilization in man. J Clin Invest (1983) 4.00
The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia (2005) 3.97
Insulin resistance in essential hypertension. N Engl J Med (1987) 3.78
Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest (1989) 3.03
Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia (2003) 2.80
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia (2005) 2.67
Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1982) 2.48
Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes (1983) 2.45
Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism (1989) 2.27
Effect of insulin on uric acid excretion in humans. Am J Physiol (1995) 2.25
Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange. Proc Natl Acad Sci U S A (1978) 2.08
Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism. J Clin Endocrinol Metab (1997) 2.04
The disposal of an oral glucose load in healthy subjects. A quantitative study. Diabetes (1985) 1.88
Splanchnic and peripheral disposal of oral glucose in man. Diabetes (1983) 1.82
Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones. J Clin Endocrinol Metab (2013) 1.82
Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes (1987) 1.76
Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects. Metabolism (1987) 1.76
Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study. Diabetes Obes Metab (2010) 1.76
Obesity and insulin resistance in humans: a dose-response study. Metabolism (1990) 1.74
Coronary hemodynamics and myocardial metabolism in patients with syndrome X: response to pacing stress. J Am Coll Cardiol (1991) 1.68
Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance. Diabetologia (2010) 1.64
Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects. Diabetologia (2005) 1.61
The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes (1992) 1.60
Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study. J Clin Endocrinol Metab (2004) 1.59
Synergistic interaction between exercise and insulin on peripheral glucose uptake. J Clin Invest (1981) 1.59
New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus. Am J Med (1983) 1.59
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes (2000) 1.57
The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1991) 1.57
Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone. Diabetes Care (2001) 1.56
Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome. Diabetologia (2000) 1.54
The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery. J Clin Endocrinol Metab (2011) 1.53
Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension. Circulation (1997) 1.53
Systemic inhibition of nitric oxide synthesis in non-diabetic individuals produces a significant deterioration in glucose tolerance by increasing insulin clearance and inhibiting insulin secretion. Diabetologia (2013) 1.51
Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones. Diabetologia (2008) 1.50
Effect of insulin on the distribution and disposition of glucose in man. J Clin Invest (1985) 1.49
Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review. Diabetologia (2006) 1.48
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes (1996) 1.46
Splanchnic and renal metabolism of insulin in human subjects: a dose-response study. Am J Physiol (1983) 1.43
Operation of Randle's cycle in patients with NIDDM. Diabetes (1990) 1.40
Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. Diabetologia (2011) 1.38
Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens (1996) 1.38
Regulation of hepatic glucose metabolism in humans. Diabetes Metab Rev (1987) 1.37
Independent influence of age on basal insulin secretion in nondiabetic humans. European Group for the Study of Insulin Resistance. J Clin Endocrinol Metab (1999) 1.37
Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study. J Clin Endocrinol Metab (2001) 1.34
Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. J Clin Invest (1993) 1.34
Effect of graded doses of insulin on splanchnic and peripheral potassium metabolism in man. Am J Physiol (1980) 1.32
Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. Diabetes (1999) 1.31
Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes (1994) 1.29
Non-steady state: error analysis of Steele's model and developments for glucose kinetics. Am J Physiol (1987) 1.28
Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. Hypertension (1992) 1.27
Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients. Diabetes (2001) 1.24
Insulin resistance in diabetic ketoacidosis. Diabetes (1982) 1.23
Hyperinsulinemia and autonomic nervous system dysfunction in obesity: effects of weight loss. Circulation (2001) 1.23
Effects of insulin on hemodynamics and metabolism in human forearm. Diabetes (1990) 1.20
Time dependence of the interaction between lipid and glucose in humans. Am J Physiol (1989) 1.19
Efficacy and safety of ipragliflozin in patients with type 2 diabetes inadequately controlled on metformin: a dose-finding study. Diabetes Obes Metab (2012) 1.16
Impact of increased visceral and cardiac fat on cardiometabolic risk and disease. Diabet Med (2012) 1.14
Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis (1989) 1.13
Glucose transport in human skeletal muscle. The in vivo response to insulin. Diabetes (1993) 1.12
Kinetic analysis of plasma insulin disappearance in nonketotic diabetic patients and in normal subjects. A tracer study with 125I-insulin. J Clin Invest (1978) 1.11
Stereospecificity of the chloride ion channel: the action of chiral clofibric acid analogues. J Med Chem (1987) 1.10
Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. J Clin Invest (1996) 1.10
Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach. Am J Physiol Endocrinol Metab (2000) 1.07
Insulin resistance and hyperinsulinemia: No independent relation to left ventricular mass in humans. Circulation (2000) 1.07
Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function. Diabetologia (2006) 1.06
Insulin action and substrate competition. Baillieres Clin Endocrinol Metab (1993) 1.05
Metabolic effects of low-dose insulin therapy on glucose metabolism in diabetic ketoacidosis. Diabetes (1988) 1.05
Effect of pioglitazone on the metabolic and hormonal response to a mixed meal in type II diabetes. Clin Pharmacol Ther (2007) 1.05
Mathematical modeling shows exenatide improved beta-cell function in patients with type 2 diabetes treated with metformin or metformin and a sulfonylurea. Horm Metab Res (2006) 1.05
The kinetics of insulin in man. II. Role of the liver. Diabetes Metab Rev (1987) 1.04
Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans. Diabetes (1999) 1.04
Pattern of insulin delivery after intravenous glucose injection in man and its relation to plasma glucose disappearance. J Clin Invest (1979) 1.03
Beta cell glucose sensitivity is decreased by 39% in non-diabetic individuals carrying multiple diabetes-risk alleles compared with those with no risk alleles. Diabetologia (2008) 1.02
Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss. Int J Obes (Lond) (2009) 1.02
Beta-cell function assessment from modelling of oral tests: an effective approach. Diabetes Obes Metab (2008) 1.01
The islet in type 2 diabetes: back to center stage. Diabetes (2001) 1.01
Evidence for an association of high blood pressure and hyperinsulinemia in obese man. J Clin Endocrinol Metab (1986) 1.01
CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study. Rheumatology (Oxford) (2008) 1.00
Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. Circulation (1995) 1.00
The kinetics of insulin in man. I. General aspects. Diabetes Metab Rev (1987) 0.99
Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? Diabetologia (1993) 0.99
Insulin prolongs the QTc interval in humans. Am J Physiol Regul Integr Comp Physiol (2000) 0.99
Effect of short-term folic acid supplementation on insulin sensitivity and inflammatory markers in overweight subjects. Int J Obes (Lond) (2006) 0.99
Glucose absorption and production following oral glucose: comparison of compartmental and arteriovenous-difference methods. Metabolism (1994) 0.98
A model for glucose control of insulin secretion during 24 h of free living. Diabetes (2001) 0.98
Renal effects of insulin in man. J Nephrol (1997) 0.97
The pathogenesis of non-insulin-dependent diabetes: an update. Medicine (Baltimore) (1982) 0.97
In vivo glucose metabolism in the awake rat: tracer and insulin clamp studies. Metabolism (1987) 0.97
Metabolic basis of obesity and noninsulin-dependent diabetes mellitus. Diabetes Metab Rev (1988) 0.97
Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1988) 0.96
Effect of obesity and insulin resistance on resting and glucose-induced thermogenesis in man. EGIR (European Group for the Study of Insulin Resistance). Int J Obes Relat Metab Disord (1999) 0.96
Lack of a gastrointestinal mediator of insulin action in maturity-onset diabetes. Lancet (1978) 0.96
The role of fractional glucose extraction in the regulation of splanchnic glucose metabolism in normal and diabetic man. Metabolism (1980) 0.96
Loss of 50% of excess weight using a very low energy diet improves insulin-stimulated glucose disposal and skeletal muscle insulin signalling in obese insulin-treated type 2 diabetic patients. Diabetologia (2007) 0.95
Hepatic and extrahepatic splanchnic glucose metabolism in the postabsorptive and glucose fed dog. Metabolism (1985) 0.95
Metabolic abnormalities of hypertension. A lesson in complexity. Hypertension (1991) 0.95
Relation of birthweight to maternal plasma glucose and insulin concentrations during normal pregnancy. Diabetologia (1993) 0.95